Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1992-04-21
1993-09-21
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
424648, 514502, 514560, A61K 3326, A61K 31295, A61K 3120
Patent
active
052467260
ABSTRACT:
Pharmaceutically acceptable compositions of one or more n-6 or n-3 essential fatty acids, particularly gamma-linolenic acid, dihomo-gamma-linolenic acid, or eicosapentaenoic acid, and assimilable iron compounds, in dosage unit form optionally with a diluent or carrier, said acids being present as such or as derivatives convertible in the body thereto and the amounts of said acids or derivatives being 1 mg to 100 g (calculated as gamma-linolenic acid) and of said iron compounds 0.1 mg to 10 g (calculated as iron) or submultiples of said amounts convenient for daily administration thereof.
REFERENCES:
patent: 3911117 (1975-10-01), Ender
patent: 4526902 (1985-07-01), Rubin
patent: 4681986 (1987-07-01), Horrobin
patent: 4745099 (1988-05-01), Akamatsu et al.
patent: 5128152 (1992-07-01), Horrobin et al.
Clinical Toxicology of Commercial Products Acute Poisoning, Gleason et al., 3rd ed. 1969.
Chemotherapy of Cancer, 2nd edition (1981) Carter et al., Appendix C, pp. 361-365.
Begin Michel E.
Horrobin David F.
Efamol Ltd.
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
Iron-containing composition and method for treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iron-containing composition and method for treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iron-containing composition and method for treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048247